Skip to main content
Journal cover image

Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial

Publication ,  Journal Article
Hurwitz, H; Uppal, N; Wagner, SA; Bendell, J; Thaddeus, BJ; Wade, S; Nemunaitis, J; Stella, P; Pipas, JM; Wainberg, Z; Manges, R; Garrett, W ...
Published in: Annals of Oncology
June 1, 2014

Duke Scholars

Published In

Annals of Oncology

DOI

EISSN

1569-8041

ISSN

0923-7534

Publication Date

June 1, 2014

Volume

25

Start / End Page

ii115

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H., Uppal, N., Wagner, S. A., Bendell, J., Thaddeus, B. J., Wade, S., … Sandor, V. (2014). Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial. Annals of Oncology, 25, ii115. https://doi.org/10.1093/annonc/mdu193.26
Hurwitz, H., N. Uppal, S. A. Wagner, J. Bendell, B. J. Thaddeus, S. Wade, J. Nemunaitis, et al. “Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial.” Annals of Oncology 25 (June 1, 2014): ii115. https://doi.org/10.1093/annonc/mdu193.26.
Hurwitz H, Uppal N, Wagner SA, Bendell J, Thaddeus BJ, Wade S, et al. Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial. Annals of Oncology. 2014 Jun 1;25:ii115.
Hurwitz, H., et al. “Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial.” Annals of Oncology, vol. 25, June 2014, p. ii115. Scopus, doi:10.1093/annonc/mdu193.26.
Hurwitz H, Uppal N, Wagner SA, Bendell J, Thaddeus BJ, Wade S, Nemunaitis J, Stella P, Pipas JM, Wainberg Z, Manges R, Garrett W, Hunter D, Clark J, Leopold L, Levy R, Sandor V. Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial. Annals of Oncology. 2014 Jun 1;25:ii115.
Journal cover image

Published In

Annals of Oncology

DOI

EISSN

1569-8041

ISSN

0923-7534

Publication Date

June 1, 2014

Volume

25

Start / End Page

ii115

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis